GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
sales of 48.83 billion Swiss Francs [US$50.70 billion]
of which 66%
was Innovative Medicines),
(34.71 billion Euro [US$41.62 billion]
of which 84%
was Pharmaceuticals), and
(£17.11 billion [US$23.12 billion]
of which 100%
During the year ended December of 2016, sales at
GlaxoSmithKline plc were £27.89 billion (US$37.69 billion).
increase of 16.6%
versus 2015, when the company's sales were £23.92 billion.
The sales level in 2016 was fairly close to the level five years ago: in 2011, GlaxoSmithKline plc had sales
of £27.39 billion.
Sales of Vaccines saw an increase
25.6% in 2016, from
£3.66 billion to £4.59 billion.